drugset
drugset / Trial / NCT04206657

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

NCT04206657 ↗

Phase 1 Completed 42 enrolled Kyowa Kirin, Inc. Kyowa Kirin China Pharmaceutical Co., Ltd. · collab
Non-randomizedSequentialOpen-labelTreatment

Summary

The primary objective is to evaluate the pharmacokinetic profile of KHK7580 in Chinese healthy adult volunteers. The secondary objective is to evaluate its safety and pharmacodynamics.

Timeline

Start
2019-12-20
Primary completion
2021-06-17
Completion
2021-06-17

Drugs

EvaluationDrugModalityDoseRoute
Subject EVOCALCET Small molecule 1 mg Oral
Subject EVOCALCET Small molecule 3 mg Oral
Subject EVOCALCET Small molecule 6 mg Oral
Subject EVOCALCET Small molecule 12 mg Oral

Indications

No indication recorded.